Rollover Study Of Lapatinib In Cancer Patients
NCT00169533
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
31
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms, Breast
Interventions
DRUG:
GW572016 oral tablets
Sponsor
GlaxoSmithKline